Swiss National Bank - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 117 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 6.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$218,000
-35.7%
56,2000.0%0.00%
Q2 2019$339,000
-59.8%
56,200
-10.7%
0.00%
-100.0%
Q1 2019$843,000
+44.1%
62,9000.0%0.00%0.0%
Q4 2018$585,000
-29.3%
62,900
+5.9%
0.00%0.0%
Q3 2018$827,000
-11.9%
59,4000.0%0.00%0.0%
Q2 2018$939,000
-7.9%
59,4000.0%0.00%0.0%
Q1 2018$1,020,000
-3.5%
59,400
+23.2%
0.00%0.0%
Q4 2017$1,057,000
-46.4%
48,2000.0%0.00%
-50.0%
Q3 2017$1,972,000
+35.9%
48,2000.0%0.00%0.0%
Q2 2017$1,451,000
-4.2%
48,200
+15.0%
0.00%0.0%
Q1 2017$1,515,000
-27.9%
41,9000.0%0.00%
-33.3%
Q4 2016$2,100,000
+0.3%
41,900
+5.0%
0.00%0.0%
Q3 2016$2,094,000
+23.5%
39,900
-2.7%
0.00%0.0%
Q2 2016$1,695,000
+24.8%
41,000
+18.5%
0.00%
+50.0%
Q1 2016$1,358,000
+23.5%
34,600
+30.6%
0.00%
-33.3%
Q4 2015$1,100,000
+169.6%
26,5000.0%0.00%
+200.0%
Q3 2015$408,000
-29.2%
26,500
+14.2%
0.00%0.0%
Q2 2015$576,00023,2000.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 115,500$2,531,0000.89%
AWM Investment Company, Inc. 150,000$3,288,0000.64%
BB BIOTECH AG 827,500$18,139,0000.51%
Virtus ETF Advisers LLC 17,371$381,0000.48%
Rock Springs Capital Management LP 425,000$9,316,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,728$9,880,0000.39%
Telemetry Investments, L.L.C. 44,176$968,0000.37%
RTW INVESTMENTS, LP 100,377$2,200,0000.37%
Eventide Asset Management 315,000$6,905,0000.36%
ACUTA CAPITAL PARTNERS, LLC 52,500$1,151,0000.22%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders